Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 1995.90 52.55 (2.70%) | NSE 1997.20 55.80 (2.87%) | Trade | Add

BSE Live

Jan 22, 16:01

1995.90 52.55 (2.70%)

Volume

AVERAGE VOLUME

5-Day

15,000

10-Day

15,876

30-Day

14,241

48,453

NSE Live

Jan 22, 16:00

1997.20 55.80 (2.87%)

Volume

AVERAGE VOLUME

5-Day

384,080

10-Day

526,162

30-Day

543,255

723,617

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Glenmark Pharma (in Rs. Cr.)	Mar 05	Mar 04
Per Share Ratios
Basic EPS (Rs.)	9.03	6.98
Diluted EPS (Rs.)	9.03	6.98
Cash EPS (Rs.)	10.70	8.85
Book Value [ExclRevalReserve]/Share (Rs.)	26.05	37.94
Book Value [InclRevalReserve]/Share (Rs.)	26.05	37.94
Revenue from Operations/Share (Rs.)	48.14	64.25
PBDIT/Share (Rs.)	13.57	12.25
PBIT/Share (Rs.)	12.19	10.38
PBT/Share (Rs.)	10.73	8.68
Net Profit/Share (Rs.)	9.03	6.98
NP After MI And SOA / Share (Rs.)	9.03	6.98
Profitability Ratios
PBDIT Margin (%)	28.18	19.06
PBIT Margin (%)	25.31	16.15
PBT Margin (%)	22.29	13.50
Net Profit Margin (%)	18.76	10.85
NP After MI And SOA Margin (%)	18.75	10.86
Return on Networth/Equity (%)	34.66	18.43
Return on Capital Employed (%)	13.79	10.91
Return on Assets (%)	11.67	9.07
Total Debt/Equity (X)	1.41	0.51
Asset Turnover Ratio (%)	62.25	83.52
Liquidity Ratios
Current Ratio (X)	3.85	3.40
Quick Ratio (X)	3.00	2.33
Inventory Turnover Ratio (X)	4.78	4.63
Dividend Payout Ratio (NP) (%)	7.75	18.62
Dividend Payout Ratio (CP) (%)	6.54	14.68
Earnings Retention Ratio (%)	92.25	81.38
Cash Earnings Retention Ratio (%)	93.46	85.32
Coverage Ratios
Interest Coverage Ratios (%)	8.37	6.11
Interest Coverage Ratios (Post Tax) (%)	8.37	6.11
Valuation Ratios
Enterprise Value (Cr.)	3,677.64	971.48
EV/Net Operating Revenue (X)	6.44	2.55
EV/EBITDA (X)	22.85	13.39
MarketCap/Net Operating Revenue (X)	5.86	2.24
Retention Ratios (%)	92.24	81.37
Price/BV (X)	10.84	3.81
Price/Net Operating Revenue	5.86	2.24
Earnings Yield	0.03	0.05